{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:00:24Z","timestamp":1785416424701,"version":"3.56.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41582-026-01242-7","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:03:39Z","timestamp":1782857019000},"page":"483-484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ataxia Global Initiative recommend MRI end-points for clinical trials in ataxias"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2305-1073","authenticated-orcid":false,"given":"H\u00e9lio A. G.","family":"Teive","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"1242_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/WCO.0000000000000227","volume":"28","author":"HAG Teive","year":"2015","unstructured":"Teive, H. A. G. & Ashizawa, T. Primary and secondary ataxias. Curr. Opin. Neurol. 28, 413\u2013422 (2015).","journal-title":"Curr. Opin. Neurol."},{"key":"1242_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-026-01218-7","author":"G \u00d6z","year":"2026","unstructured":"\u00d6z, G. et al. MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group. Nat. Rev. Neurol. https:\/\/doi.org\/10.1038\/s41582-026-01218-7 (2026).","journal-title":"Nat. Rev. Neurol."},{"key":"1242_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","volume":"14","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa, T., \u00d6z, G. & Paulson, H. L. Spinocerebellar ataxias: prospects and challenges for therapy development. Nat. Rev. Neurol. 14, 590\u2013605 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1242_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.molmed.2024.07.008","volume":"31","author":"MLS Eisel","year":"2025","unstructured":"Eisel, M. L. S. et al. Emerging therapies in hereditary ataxias. Trends Mol. Med. 31, 181\u2013194 (2025).","journal-title":"Trends Mol. Med."},{"key":"1242_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.25934","volume":"89","author":"DR Lynch","year":"2021","unstructured":"Lynch, D. R. et al. Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study). Ann. Neurol. 89, 212\u2013225 (2021).","journal-title":"Ann. Neurol."},{"key":"1242_CR6","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch, T. et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66, 1717\u20131720 (2006).","journal-title":"Neurology"},{"key":"1242_CR7","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1212\/01.WNL.0000156802.15466.79","volume":"64","author":"SH Subramony","year":"2005","unstructured":"Subramony, S. H. et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology 64, 1261\u20131262 (2005).","journal-title":"Neurology"},{"key":"1242_CR8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.29032","volume":"37","author":"T Klockgether","year":"2022","unstructured":"Klockgether, T. et al. Paving the way toward meaningful trials in ataxias: an Ataxia Global Initiative perspective. Mov. Disord. 37, 1125\u20131130 (2022).","journal-title":"Mov. Disord."},{"key":"1242_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s12311-023-01572-y","volume":"23","author":"G \u00d6z","year":"2024","unstructured":"\u00d6z, G. et al. MR imaging in ataxias: consensus recommendations by the Ataxia Global Initiative Working Group on MRI Biomarkers. Cerebellum 23, 931\u2013945 (2024).","journal-title":"Cerebellum"},{"key":"1242_CR10","first-page":"924","volume":"21","author":"T Klockgether","year":"2024","unstructured":"Klockgether, T., Synofzik, M. & AGI working group on COAs and Registries. Consensus recommendations for clinical outcome assessments and registry development in ataxias: Ataxia Global Initiative (AGI) working group expert guidance. Cerebellum 21, 924\u2013930 (2024).","journal-title":"Cerebellum"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01242-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01242-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01242-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:01:55Z","timestamp":1785412915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-026-01242-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1038\/s41582-026-01242-7","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"30 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}